Health Problems

Price of alirocumab would have to be cut to be cost-effective

(HealthDay)—For patients with a recent acute coronary syndrome receiving a statin, the price of alirocumab would have to be reduced to be cost-effective, according to a study published online Jan. 1 in the Annals of Internal Medicine. Dhruv S. Kazi, M.D., from the Beth Israel Deaconess Medical Center in Boston, and colleagues examined the cost-effectiveness […]